Beginning Cash: The amount of cash reported by the company on its previous statement.
Beam Therapeutics Inc. (BEAM) had Beginning Cash of $290.11M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$114.11M |
|
$244.30M |
|
-- |
|
$114.11M |
|
$131.55M |
|
$-17.45M |
|
$261.74M |
|
$244.30M |
|
$244.30M |
|
$244.30M |
|
$244.30M |
|
$244.30M |
|
$244.30M |
|
$-17.45M |
|
$-15.04M |
|
98.91M |
|
98.91M |
|
$2.53 |
|
$2.53 |
|
| Balance Sheet Financials | |
$1.27B |
|
$104.50M |
|
$212.49M |
|
$1.48B |
|
$96.94M |
|
-- |
|
$145.88M |
|
$242.82M |
|
$1.24B |
|
$1.24B |
|
$1.24B |
|
101.75M |
|
| Cash Flow Statement Financials | |
$-345.10M |
|
$-121.44M |
|
$478.05M |
|
|
Beginning Cash |
$290.11M |
$301.62M |
|
$11.51M |
|
$94.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-15.29% |
|
-15.29% |
|
-- |
|
214.09% |
|
214.09% |
|
$-360.05M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
19.73% |
|
19.73% |
|
16.49% |
|
19.73% |
|
$12.17 |
|
$-3.64 |
|
$-3.49 |
|